Compare RemeGen Co., Ltd. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-36.41%
0%
-36.41%
6 Months
-22.03%
0%
-22.03%
1 Year
10.59%
0%
10.59%
2 Years
350.65%
0%
350.65%
3 Years
75.89%
0%
75.89%
4 Years
70.39%
0%
70.39%
5 Years
-28.8%
0%
-28.8%
RemeGen Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
259.61%
EBIT Growth (5y)
23.54%
EBIT to Interest (avg)
-95.55
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.11
Sales to Capital Employed (avg)
0.37
Tax Ratio
0.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.97%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
Price to Book Value
3.48
EV to EBIT
40.26
EV to EBITDA
32.52
EV to Capital Employed
4.06
EV to Sales
3.94
PEG Ratio
0.40
Dividend Yield
NA
ROCE (Latest)
10.08%
ROE (Latest)
7.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
740.50
1,679.60
-55.91%
Operating Profit (PBDIT) excl Other Income
-29.20
679.90
-104.29%
Interest
15.10
14.40
4.86%
Exceptional Items
407.60
702.50
-41.98%
Consolidate Net Profit
370.10
1,382.50
-73.23%
Operating Profit Margin (Excl OI)
-39.40%
404.80%
-44.42%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -55.91% vs 147.18% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -73.23% vs 1,351.13% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,515.50
1,854.20
89.60%
Operating Profit (PBDIT) excl Other Income
480.60
-1,451.50
133.11%
Interest
76.10
78.50
-3.06%
Exceptional Items
696.40
1.70
40,864.71%
Consolidate Net Profit
769.60
-1,592.00
148.34%
Operating Profit Margin (Excl OI)
37.90%
-856.40%
89.43%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 89.60% vs 55.93% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 148.34% vs 4.66% in Dec 2024
About RemeGen Co., Ltd. 
RemeGen Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






